Goldman Sachs Upgrades Genmab A/S (GMAB) to Buy

Goldman Sachs analyst Rajan Sharma upgraded Genmab A/S (NASDAQ: GMAB) from Neutral to Buy with a price target of $30.50 (from $24.50).

For an analyst ratings summary and ratings history on Genmab A/S click here. For more ratings news on Genmab A/S click here.

Shares of Genmab A/S closed at $27.06 yesterday.

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
• GMR Airports Infrastructure (GMRI:IN) PT Raised to INR99 at ICICI Securities